Anti-Human T-Lymphocyte Immunoglobulin From Rabbits

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

4 Sponsors

13 Countries

Phase II/III

Phase II

Phase II/III: 1 Phase II: 3

Indications tested

Kidney transplant rejection 1 Relapsing-remitting multiple sclerosis 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S 1 Hansa Biopharma AB 1 St. Anna Childrens Cancer Research Institute GmbH 1

All trials

4 total

Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting

2022-500230-28-00 Phase II 4 countries Hansa Biopharma AB
Randomized Phase 2 study testing two conditioning regimen with a single prophylaxis of graft-versus-host disease by cyclophosphamide and met… Recruiting

2023-509042-35-01 Phase II 1 country Centre Hospitalier Universitaire De Nantes
ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting

2024-512657-24-00 Phase II/III 12 countries St. Anna Childrens Cancer Research Institute GmbH
No Evidence Of Disease Activity After Autologous Haematopoietic Stem Cell Transplantation In Aggressive Multiple Sclerosis Ended

2024-515470-26-00 Phase II 1 country Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S

Showing 1–4 of 4 trials

← All drugs A–Z